Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Electronic Prescribing of Controlled Substances
Tell a Friend About This EventTell a Friend
 

Connecticut Public Act 17-131, Section 3, requires Electronic Prescribing of Controlled Substances (EPCS) starting on January 1, 2018, for all controlled substances. The legislature passed the mandate to help reduce prescription fraud with fewer opportunities to duplicate or modify paper prescriptions.

12/7/2017
When: Thursday, December 7
12 noon to 2:00 pm
Where: Norwalk Inn & Conference Center
99 East Avenue
Norwalk, CT  06851
Contact: Juanita Martino
203-513-2045


Online registration is closed.
« Go to Upcoming Event List  

UNDERSTANDING THE CONNECTICUT ELECTRONIC
PRESCRIBING OF CONTROLLED SUBSTANCES AND
HOW TO DETECT DRUG DIVERSION IN YOUR PRACTICE

Presented by:

Rodrick Marriott, Pharm D, Director of the Drug Control Division,
Connecticut Department of Consumer Protection
AND
Lourdes Martinez, Esq., Garfunkel Wild, PC


Connecticut Public Act 17-131, Section 3, requires Electronic Prescribing of Controlled Substances (EPCS) starting on January 1, 2018, for all controlled substances. The legislature passed the mandate to help reduce prescription fraud with fewer opportunities to duplicate or modify paper prescriptions.

During this presentation the following areas will be addressed:

  • What is Electronic Prescribing of Controlled Substances?
  • What is required to transmit an electronic Schedule II-V Controlled Substances Prescription?
  • Which medication must be electronically prescribed?
  • What exception exists for Electronic Prescribing of Controlled Substances?
  • What procedure must be followed when a patient’s pharmacy is outside of Connecticut?
  • What procedure must be followed when issuance of an Electronic Prescription of a Controlled Substances negatively impacts patient care?
  • What is the procedure for filing for an Electronic Prescribing of Control Substances exemption?
  • Does a medical practice have to purchase software to comply with Electronic Prescribing of Controlled Substances?
  • What warning signs may indicate the possibility of diversion in your practice?
  • What can you do to minimize the changes of drug diversion?
  • What actions must you take when there is evidence of drug diversion in your practice?













A question and answer period will follow the presentation.

In the interest of full disclosure, the speaker and his/her company, product(s), or service(s) is neither a preferred vendor nor endorsed by FCMA.

 

FCMA members and office staff are invited. Lunch included

Limited seating; register early.  Refunds will be given if we

receive your cancellation within three (3) business days of the event.


Sign In
Sign In securely